Camber Pharmaceuticals Launches Generic Concerta®

Piscataway, NJ, September 5, 2019– Camber Pharmaceuticals is pleased to announce the addition of Methylphenidate ER Tablets to our growing portfolio of products.
Methylphenidate ER tablets are the generic version of Concerta®. Methylphenidate is used to treat attention-deficit hyperactivity disorder (ADHD). Methylphenidate ER tablets are available in a 18, 27, 36 and 54 mg- 100ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025